Immutep (IMMP) Net Income (2012 - 2024)
Immutep's (IMMP) quarterly Net Income came in at -$2.6 million in Q4 2024, down 113.59% YoY from $19.4 million in Q1 2024, and down 4.37% on a QoQ basis from -$2.5 million in Q2 2024.
Immutep (IMMP) Net Income (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 10 years of Net Income data on file, last reported at -$2.6 million in Q4 2024.
- Quarterly Net Income fell 113.59% year-over-year to -$2.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$5.2 million (up 19.3% YoY) and the FY2025 annual result came in at -$39.3 million, down 35.26% from the prior year.
- Net Income slipped to -$2.6 million in Q4 2024, from -$2.5 million in the prior quarter.
- In the past five years, Net Income ranged from a high of -$422669.6 in Q4 2021 to a low of -$2.6 million in Q4 2024.
- A 4-year average of -$1.5 million and a median of -$1.2 million in 2023 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income retreated 26.34% — and 2023, when it tumbled 131.58%.
- Tracing IMMP's Net Income over 4 years: stood at -$422669.6 in 2021, then fell by 26.34% to -$534020.1 in 2022, then slumped by 131.58% to -$1.2 million in 2023, then slumped by 113.59% to -$2.6 million in 2024.
- The last three Net Income figures came in at -$2.6 million (Q4 2024), -$2.5 million (Q2 2024), and -$1.2 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.53 Mn |
| Dec 31, 2023 | -1.24 Mn |
| Dec 31, 2022 | -534,020.09 |
| Dec 31, 2021 | -422,669.57 |
| Dec 31, 2019 | -670,750.76 |
| Jun 30, 2019 | -1.30 Mn |
| Dec 31, 2018 | -944,731.60 |
| Jun 30, 2017 | -1.96 Mn |
| Mar 31, 2017 | -1.69 Mn |
| Dec 31, 2016 | -47,793.34 |
| Jun 30, 2016 | -1.52 Mn |
| Mar 31, 2016 | -1.79 Mn |
| Jun 30, 2015 | -4.98 Bn |
| Dec 31, 2012 | 69,562.20 |